Clinical trial
Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and…
NCT00003875 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003875 |
|---|---|
| Title | Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia |
| Official title | Treatment of Acute Myelogenous Leukemia With Busulfan and Etoposide Followed by Autologous or Syngeneic Stem Cell Rescue and Low-Dose Interleukin 2 (IL-2) Immunotherapy |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(15, 17)(q22, q12), Adult Acute Myeloid Leukemia With t(16, 16)(p13, q22), Childhood Acute Myeloid Leukemia in Remission and 2 more |
| Intervention type | Biological, Drug, Procedure |
| Interventions | busulfan, etoposide, aldesleukin, peripheral blood stem cell transplantation |
| Enrollment | 30 |
| Start date | Oct 13, 1998 |
| Primary completion | Jun 11, 2015 |
| Completion | Jun 11, 2015 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 5, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: